Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity
Open Access
- 28 September 2004
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (10), 1700-1708
- https://doi.org/10.1111/j.1538-7836.2004.00944.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/BioclateR): a prospective pharmacovigilance studyHaemophilia, 2004
- Recombinant Factor VIIa in the Treatment of BleedingAmerican Journal of Clinical Pathology, 2004
- Recombinant Factor VIIa in the Treatment of BleedingAmerican Journal of Clinical Pathology, 2004
- Adverse reactions related to rVIIa?American Journal of Hematology, 2001
- Expression of Tissue Factor in High-Grade Carotid Artery StenosisStroke, 2001
- Temporal Patterns of NSAID Spontaneous Adverse Event ReportsDrug Safety, 2001
- Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitorsBritish Journal of Haematology, 2000
- Is reporting rate a good predictor of risks associated with drugs?British Journal of Clinical Pharmacology, 1999
- Pharmacovigilance in the pharmaceutical industryBritish Journal of Clinical Pharmacology, 1998
- Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study GroupTransfusion, 1990